[1] Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time? : A systematic review. Am J Respir Crit Care Med. 2009;179(3): 220-227. [2] Silversides JA, Ferguson ND. Clinical review: Acute respiratory distress syndrome - clinical ventilator management and adjunct therapy. Crit Care. 2013;17(2):225. [3] 许婧.脂肪间充质干细胞增殖和定向分化能力与p16ink4a基因表达的关系[D].长沙:湘雅医学院,2013.[4] Lu F, Mizuno H, Uysal CA, et al. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg. 2008;121(1):50-58. [5] Fernandes M, Valente SG, Sabongi RG, et al.Bone marrow-derived mesenchymal stem cells versus adipose-derived mesenchymal stem cells for peripheral nerve regeneration.Neural Regen Res. 2018;13(1):100-104.[6] Sun CK, Lee FY, Kao YH, et al. Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. J Pineal Res. 2015;58(2): 137-150. [7] Hayes M, Curley G, Ansari B, et al. Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype. Crit Care. 2012;16(2):205. [8] Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93-98. [9] Sharifov OF, Xu X, Gaggar A, et al. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS One. 2013;8(5):e64486. [10] Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-150. [11] Nakanishi C, Nagaya N, Ohnishi S, et al. Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. Circ J. 2011;75(9): 2260-2268. [12] Toyoda M, Matsubara Y, Lin K, et al. Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omental adipose tissues. Cell Biochem Funct. 2009;27(7):440-447. [13] Melief SM, Zwaginga JJ, Fibbe WE, et al. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2(6):455-463. [14] Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012;21(14):2724-2752. [15] Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4(1):31-36. [16] Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. [17] Xiang M, Fan J. Pattern recognition receptor-dependent mechanisms of acute lung injury. Mol Med. 2010;16(1-2): 69-82. [18] Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169(6): 3155-3162. [19] Wang X, Moser C, Louboutin JP, et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol. 2002;168(2): 810-815. [20] Branger J, Knapp S, Weijer S, et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004;72(2):788-794. [21] Su Q, Grabowski M, Weindl G. Recognition of Propionibacterium acnes by human TLR2 heterodimers. Int J Med Microbiol. 2017;307(2):108-112. [22] 张玖强,张兴毅,李莹.ToLL样受体4的临床应用研究进展[J].中国急救医学,2012,32(9):849-851.[23] Gosemann JH, van Griensven M, Barkhausen T, et al. TLR4 influences the humoral and cellular immune response during polymicrobial sepsis. Injury. 2010;41(10):1060-1067.[24] Gaikwad S, Naveen C, Agrawal-Rajput R.Toll-like receptor-4 antagonism mediates benefits during neuroinflammation. Neural Regen Res. 2016;11(4):552-553. |